Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study

2005239 citationsJournal Article

Authors

With a good safety profile, a promising response rate, and an improvement in QOL, Folfirinox will be further assessed in a phase III trial.

Published in: Journal of Clinical Oncology

Volume 23, Issue 6, pp. 1228-1236

Field-Weighted Citation Impact: 2.95